These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Use of benzodiazepines to control disruptive behavior in inpatients.
    Author: Salzman C.
    Journal: J Clin Psychiatry; 1988 Dec; 49 Suppl():13-5. PubMed ID: 3058683.
    Abstract:
    The author reviews prior evidence and presents data from his prospective study comparing intramuscular lorazepam with intramuscular haloperidol for control of extreme, agitated psychotic behavior; the data demonstrate that lorazepam is effective and has fewer side effects than haloperidol. The effective intramuscular dose is 1 to 2 mg in conjunction with ongoing neuroleptic antipsychotic treatment. Lorazepam does not prevent future disruptive behavior, and data do not support its use as an agent for maintenance therapy.
    [Abstract] [Full Text] [Related] [New Search]